Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Vial will be at the OIS Retina Innovation Summit 2022

July 13, 2022 | New York, NY

We are looking forward to connecting with you at the 2022 Ophthalmology Innovation Summit!

Meet with us

Let us know if you’d like to connect with us before the event by filling out the form below.

Vial staff attending the event:

Simon Burns
Simon Burns
Co-founder & Chief Executive Officer
Andrew Brackin
Andrew Brackin
Co-founder & Chief Revenue Officer
John Sheperdson
Strategic Growth Executive
Duke Moran
Senior Account Executive

Meet with us!

Name(Required)
By submitting, you are agreeing to our terms and privacy policy